A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

NCT00924560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1361

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Mineral Density

Interventions

DRUG: 91-day Levonorgestrel Oral Contraceptive
DRUG: 28-day Levonorgestrel Oral Contraceptive

Sponsor

Duramed Research